08:11 AM EST, 03/08/2024 (MT Newswires) -- Steve Pakola, Chief Medical Officer, on March 05, 2024, sold 12,878 shares in Regenxbio ( RGNX ) for $365,220. Following the Form 4 filing with the SEC, Pakola has control over a total of 107,192 shares of the company, with 107,192 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1590877/000156218024002430/xslF345X03/primarydocument.xml

Price: 23.69, Change: +0.46, Percent Change: +1.99